Manufacturing

NVS
Favicon Fierce Pharma

Novartis pledges nearly $480M to bolster China production, R&D

Amid a spate of pharma investments in China, Novartis is the latest drugmaker lining up to bolster its R&D and production operations in the country.
Fraiser Kansteiner Mar 23, 2026 10:35am
AstraZeneca
Favicon Fierce Pharma

AZ to build cell therapy supply hub, R&D center in Shanghai

Mar 19, 2026 10:20am
FDA
Favicon Fierce Pharma

FDA approves leucovorin without clinical trial—but not for autism

Mar 10, 2026 9:00am
whale jumping out of water
Favicon Fierce Pharma

Orca rides $250M funding wave toward cancer cell therapy launch

Jan 9, 2026 11:19am
2026 year ahead look ahead preview forecast new year
Favicon Fierce Pharma

3 biopharma CEOs explain why they are 'authentically optimistic'

Jan 6, 2026 11:54am
WuXi
Favicon Fierce Pharma

WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg

Dec 4, 2025 8:55am